RDEA119/BAY 869766: A potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer - Iverson, C; Larson, G; Lai, C; Yeh, L T; Dadson, C; Weingarten, P; Appleby, T; Vo, T; Maderna, A; Vernier, J M; Hamatake, R; Miner, J N; Quart, B (Cancer Res, 2009)